Latest filing published 17 Jun 2026 for BioXcel Therapeutics, Inc.. Read the official filing
No signal scores available.
Javier Rodriguez appears in our data through filings on BioXcel Therapeutics, Inc. shares, published by SEC (Form 4). We count 21 filings; the first trade dates from 14 March 2023 and the latest from 15 June 2026.
The open-market record consists of 1 sale worth €6,117, with no purchase. Besides market trades, the filings include 2 share grants and 18 option exercises. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 17 June 2026, the filings show an option exercise in BioXcel Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations